This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

MAURICE A. SCHNITKER, M.D.; SAMUEL A. LEVINE, M.D.

Arch Intern Med. 1937;60(2):240-250.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

During the treatment of patients with congestive heart failure we have occasionally observed that from twenty-four to forty-eight hours after diuresis has been produced by the use of salyrgan or mercurin (the sodium salt of trimethylcyclopentane-dicarboxylic acid-methoxymercuryhydroxideallylamide) or with theophylline the patient has become ill, with nausea, vomiting, giddiness, headache and considerable weakness. In fact, in the past several years one of us has seen two patients, not alarmingly ill before such supplemental diuresis, come to rapid unexpected death in this sickness a day or two after salyrgan had been given. It is this occasional postdiuretic illness that initiated the present investigation.

There are several hypotheses that may be offered as an explanation of the symptoms that may follow diuresis induced with salyrgan. When given in the usual doses, of 1 or 2 cc., this drug may produce no diuresis, in which case the mercury may be retained in the . . . [Full Text PDF of this Article]

Author Affiliations
BOSTON

From the Medical Clinic of the Peter Bent Brigham Hospital and the Department of Biochemistry and the Department of Pharmacology of the Harvard Medical School.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?